Compare HP Inc (HPQ) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HP Inc vs Nuwellis Inc — how do they compare? HP Inc trades at $24.8 (market cap $22.15B), while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: HP Inc is far larger — about 20321.1× Nuwellis Inc's market cap, and HP Inc pays a 4.95% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| HPQ | NUWE | |
|---|---|---|
Market Cap | $22.15B | $1.09M |
Sector | Technology | Technology |
52-Week High | $29.35 | $527.46 |
52-Week Low | $18.20 | $2.80 |
Enterprise Value | $29.31B | -$722.58K |
Dividend Yield | 4.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPQ trades at $24.81, down 0.12% on the day, with a bullish technical signal from moving averages and a neutral RSI. The stock shows attractive valuation with a P/E of 8.97 and P/S of 0.4, supported by consistent earnings beats in recent quarters. Recent news highlights AI-driven upgrade cycles and strategic partnerships, including with OpenAI, positioning HP for growth in the AI PC market. Cash flow trends have improved, with net cash flow turning positive in 2025.
The outlook for HPQ is cautiously optimistic, driven by potential AI PC adoption and solid fundamentals, but risks include competitive pressures and cyclical demand. Analyst consensus is mixed with a hold rating, and the current price is above the consensus target of $22.00, suggesting limited near-term upside. Investors should weigh the dividend yield and valuation against market volatility and execution risks.
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
